|
Delayed
NSE India S.E.
03:49:21 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 10.62 INR | -0.84% |
|
-3.98% | -45.29% |
Business description: Nectar Lifesciences Limited

Number of employees: 111
Sales by Activity: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals Products | 16.69B | 15.24B | 16.85B | 16.7B | - |
Geographical breakdown of sales: Nectar Lifesciences Limited
| Fiscal Period: March | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|
India | 11.81B | 8.45B | 11.46B | 11.72B | - |
Outside India | 7.45B | 9.01B | 7.79B | 7.37B | - |
Executive Committee: Nectar Lifesciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 2022-11-13 |
| Compliance Officer | - | 2025-03-31 |
Composition of the Board of Directors: Nectar Lifesciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 1995-06-26 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 2019-02-10 |
| Director/Board Member | 75 | 2021-09-20 | |
Indu Pal Kaur
BRD | Director/Board Member | 61 | 2022-08-01 |
Company details: Nectar Lifesciences Limited

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.84% | -3.98% | -26.25% | -56.83% | 21.68M | ||
| -1.29% | -1.28% | +15.48% | +61.29% | 46.63B | ||
| +1.62% | +4.94% | +47.41% | +121.09% | 37.98B | ||
| -2.95% | -0.44% | +18.65% | +90.66% | 12.48B | ||
| -1.26% | -1.52% | -9.40% | +15.15% | 11.61B | ||
| -0.19% | +0.19% | +18.18% | +137.44% | 8.92B | ||
| +0.56% | -2.53% | +37.79% | -16.85% | 6.95B | ||
| +0.89% | -1.58% | +23.34% | +40.90% | 6.93B | ||
| -2.21% | -3.66% | +22.11% | +182.99% | 7.18B | ||
| +0.30% | -3.94% | -49.55% | +1.01% | 4.95B | ||
| Average | -0.52% | -0.38% | +9.78% | +57.69% | 14.37B | |
| Weighted average by Cap. | -0.38% | +0.86% | +21.90% | +79.88% |
- Stock Market
- Stocks
- NECLIFE Stock
- Company Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions

















